Glenview Trust co Sells 2,687 Shares of Kimberly-Clark Co. (NYSE:KMB)

Glenview Trust co decreased its stake in Kimberly-Clark Co. (NYSE:KMB) by 9.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,873 shares of the company’s stock after selling 2,687 shares during the period. Glenview Trust co’s holdings in Kimberly-Clark were worth $3,259,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Marshall Investment Management LLC acquired a new stake in shares of Kimberly-Clark in the 4th quarter valued at $25,000. Migdal Insurance & Financial Holdings Ltd. bought a new position in Kimberly-Clark during the 4th quarter worth about $25,000. Darwin Wealth Management LLC acquired a new stake in Kimberly-Clark in the 3rd quarter valued at approximately $29,000. Roxbury Financial LLC acquired a new stake in Kimberly-Clark in the 4th quarter valued at $33,000. Finally, Golden State Wealth Management LLC bought a new position in Kimberly-Clark in the fourth quarter valued at approximately $32,000. Institutional investors own 76.29% of the company’s stock.

Kimberly-Clark Stock Performance

Shares of KMB stock opened at $139.79 on Monday. The company has a market capitalization of $46.36 billion, a price-to-earnings ratio of 18.52, a price-to-earnings-growth ratio of 4.46 and a beta of 0.36. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80. The company’s 50-day moving average is $133.53 and its 200 day moving average is $136.40. Kimberly-Clark Co. has a one year low of $123.02 and a one year high of $150.45.

Kimberly-Clark (NYSE:KMB) last posted its earnings results on Tuesday, January 28th. The company reported $1.50 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.50. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%. Sell-side analysts expect that Kimberly-Clark Co. will post 7.5 EPS for the current fiscal year.

Kimberly-Clark Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 2nd. Stockholders of record on Friday, March 7th will be given a dividend of $1.26 per share. The ex-dividend date of this dividend is Friday, March 7th. This is an increase from Kimberly-Clark’s previous quarterly dividend of $1.22. This represents a $5.04 dividend on an annualized basis and a dividend yield of 3.61%. Kimberly-Clark’s dividend payout ratio is presently 66.75%.

Insiders Place Their Bets

In related news, VP Andrew Drexler sold 10,838 shares of Kimberly-Clark stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $141.00, for a total transaction of $1,528,158.00. Following the completion of the sale, the vice president now owns 7,720 shares of the company’s stock, valued at $1,088,520. The trade was a 58.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.62% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on KMB shares. TD Cowen lowered Kimberly-Clark from a “buy” rating to a “hold” rating and set a $145.00 price objective on the stock. in a research note on Wednesday, January 8th. Barclays cut their price target on Kimberly-Clark from $144.00 to $132.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Citigroup decreased their target price on shares of Kimberly-Clark from $125.00 to $118.00 and set a “sell” rating on the stock in a report on Wednesday, January 15th. StockNews.com raised Kimberly-Clark from a “hold” rating to a “buy” rating in a report on Thursday, March 6th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Kimberly-Clark from $140.00 to $124.00 and set an “underweight” rating on the stock in a research note on Thursday, January 16th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $143.64.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.